logo

BAJAJHCARE vs GRANULES: Stock Comparison

BAJAJ HEALTHCARE vs GRANULES INDIAUpdated 22 Oct 26, 4:08 PM ISTNSE & company filings

GRANULES INDIA is the larger company by market capitalisation. BAJAJ HEALTHCARE shows a higher dividend yield, while GRANULES INDIA shows a lower P/E, a higher ROE and faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

BAJAJHCARE leads 5; GRANULES leads 8 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

BAJAJHCAREGRANULES

Valuation lens

What price are you paying?

Market CapContext only
₹1,091 Cr
₹22,358 Cr
P/E RatioGRANULES has the lower reading
50.38x
30.39x ✓
P/B RatioBAJAJHCARE has the lower reading
1.96x ✓
3.99x
EPSBAJAJHCARE has the higher reading
₹7.31 ✓
₹7.26
Book ValueContext only
₹165.64
₹205.21
Dividend YieldBAJAJHCARE has the higher reading
0.44% ✓
0.22%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
GRANULES is the larger company
₹22,358 Cr vs ₹1,091 Cr
P/E Ratio
GRANULES has a lower P/E
30.39x vs 50.38x
P/B Ratio
BAJAJHCARE has a lower P/B
1.96x vs 3.99x
EPS
BAJAJHCARE has higher earnings per share
₹7.31 vs ₹7.26
Dividend Yield
BAJAJHCARE has a higher dividend yield
0.44% vs 0.22%
Revenue Growth (TTM YoY)
GRANULES has faster revenue growth
22.8% vs -0.9%
EPS Growth (TTM YoY)
GRANULES has faster EPS growth
31.3% vs 0%
Qtr Sales Growth
BAJAJHCARE has stronger quarterly sales growth
6.2% vs 0%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricBAJAJHCAREGRANULES
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricBAJAJHCAREGRANULES
Live Price₹324.65₹817
Day Change-0.25%1.16%
Volume87,9235.12 L
52-Week High₹488.9₹923.65
52-Week Low₹272.35₹529.85
Distance from 52W High-33.6%-11.55%

Valuation

MetricBAJAJHCAREGRANULES
Market Cap₹1,091 Cr₹22,358 Cr
P/E Ratio50.38x30.39x
P/B Ratio1.96x3.99x
EPS₹7.31₹7.26
Book Value₹165.64₹205.21
Dividend Yield0.44%0.22%

Growth

MetricBAJAJHCAREGRANULES
Revenue Growth (TTM YoY)-0.9%22.8%
EPS Growth (TTM YoY)0%31.3%
Qtr Sales Growth6.2%0%
Qtr Profit Growth2.89%0%

Profitability & Leverage

MetricBAJAJHCAREGRANULES
ROE4%9.11%
ROCE5.17%9.07%
Net Margin2.56%11.15%
Operating Margin8.37%17.19%
Debt to Equity0.44x0.17x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricBAJAJHCAREGRANULES
Promoter Holding58.59%▲ 0.3 pp37.08%▼ 0.59 pp
FII Holding2.19%▲ 0.21 pp20.25%▲ 2.75 pp
DII Holding1.92%▼ 0.99 pp15.33%▼ 0.78 pp
Public Holding37.3%▲ 0.48 pp27.04%▼ 1.34 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: BAJAJ HEALTHCARE and GRANULES INDIA.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.